首页> 外文会议>MikroSystemTechnik Kongress >One-step antibody immobilization-based high sensitivity immunoassay procedure for potential in vitro diagnostics
【24h】

One-step antibody immobilization-based high sensitivity immunoassay procedure for potential in vitro diagnostics

机译:基于一步抗体固定的高灵敏度免疫测定程序,用于潜在的体外诊断

获取原文

摘要

A potential one-step antibody (Ab) immobilization strategy was developed for the leach-proof binding of capture Ab to the polystyrene microtiter plate (MTP) [1-3]. It enables the development of high sensitivity, cost-effective and analytically superior immunoassay (IA) for potential in vitro diagnostic (IVD) kits. The NIF-based IA detected HFA in the range of 4.9 pg mL~(-1)-20 ng mL~(-1) with limit of detection (LOD) of 7 pg mL~(-1) (Fig. 1B (a)). The analytical sensitivity was 10 pg mL~(-1), which was 51-fold more sensitive than the convention immobilization format (CIF) based commercial ELI-SA.
机译:潜在的一步抗体(AB)的固定策略是为捕获AB的浸出式结合而开发了聚苯乙烯微量滴定板(MTP)[1-3]。它能够为潜在的体外诊断(IVD)试剂盒进行高灵敏度,成本效益和分析的免疫测定(IA)的高灵敏度,经济效益和分析性优异的免疫测定(IA)。基于NIF的IA检测到的HFA在4.9pg ml〜(-1)-20ng ml〜(-1)的范围内,具有7pg ml〜(-1)的检测限(LOD)(图1B(a )))。分析敏感性为10 pg ml〜(-1),比序列固定形式(CIF)的商业Eli-SA更敏感,为51倍。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号